NFE2L2 and Cirrhosis: Our findings provide a strong rationale for exploring the therapeutic effects of Nrf2 activators and/or anti-oxidants in an attempt to modulate the inflammatory cascade at early stages of cirrhosis and potentially reduce the incidence of disease progression and clinical decompensations.